These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35629204)

  • 1. Frequency of
    Dorado P; Santos-Díaz G; Gutiérrez-Martín Y; Suárez-Santisteban MÁ
    J Pers Med; 2022 May; 12(5):. PubMed ID: 35629204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2C9 promoter variable number tandem repeat polymorphism regulates mRNA expression in human livers.
    Wang D; Sun X; Gong Y; Gawronski BE; Langaee TY; Shahin MH; Khalifa SI; Johnson JA
    Drug Metab Dispos; 2012 May; 40(5):884-91. PubMed ID: 22289258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a variable number tandem repeat in the CYP2C9 promoter on warfarin sensitivity and responsiveness in Jordanians with cardiovascular disease.
    Al-Eitan LN; Almasri AY; Al-Habahbeh SO
    Pharmgenomics Pers Med; 2019; 12():15-22. PubMed ID: 30962704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarity in recombination rate and linkage disequilibrium at CYP2C and CYP2D cytochrome P450 gene regions among Europeans indicates signs of selection and no advantage of using tagSNPs in population isolates.
    Pimenoff VN; Laval G; Comas D; Palo JU; Gut I; Cann H; Excoffier L; Sajantila A
    Pharmacogenet Genomics; 2012 Dec; 22(12):846-57. PubMed ID: 23089684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers.
    Dorado P; Cavaco I; Cáceres MC; Piedade R; Ribeiro V; Llerena A
    Eur J Clin Pharmacol; 2008 Oct; 64(10):967-70. PubMed ID: 18548238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage disequilibrium between the CYP2C19*2,*17 and CYP2C9*1 alleles and impact of VKORC1, CYP2C9, CYP2C19 gene polymorphisms and gene-gene interactions on warfarin therapy.
    Khalighi K; Cheng G; Mirabbasi S; Khalighi B; Wu Y; Fan W
    J Thromb Thrombolysis; 2017 Jan; 43(1):124-129. PubMed ID: 27743182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.
    Scott SA; Jaremko M; Lubitz SA; Kornreich R; Halperin JL; Desnick RJ
    Pharmacogenomics; 2009 Aug; 10(8):1243-55. PubMed ID: 19663669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of CYP2C9 polymorphisms in the south of Europe.
    Sánchez-Diz P; Estany-Gestal A; Aguirre C; Blanco A; Carracedo A; Ibáñez L; Passiu M; Provezza L; Ramos-Ruiz R; Ruiz B; Salado-Valdivieso I; Velasco EA; Figueiras A
    Pharmacogenomics J; 2009 Oct; 9(5):306-10. PubMed ID: 19381164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2C9 promoter region single-nucleotide polymorphisms linked to the R150H polymorphism are functional suggesting their role in CYP2C9*8-mediated effects.
    Cavallari LH; Vaynshteyn D; Freeman KM; Wang D; Perera MA; Takahashi H; Drozda K; Patel SR; Jeong H
    Pharmacogenet Genomics; 2013 Apr; 23(4):228-31. PubMed ID: 23376925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haplotype structures of common variants of CYP2C8, CYP2C9, and ADRB1 genes in a South Indian population.
    Arun Kumar AS; Chakradhara Rao US; Umamaheswaran G; Ramu P; Kesavan R; Shewade DG; Balachandar J; Adithan C
    Genet Test Mol Biomarkers; 2011 Jun; 15(6):407-13. PubMed ID: 21375401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of CYP2C9*11 Allelic Variant on the Pharmacokinetics of Phenytoin and (S)-Warfarin.
    Wanounou M; Shaul C; Abu Ghosh Z; Alamia S; Caraco Y
    Clin Pharmacol Ther; 2022 Jul; 112(1):156-163. PubMed ID: 35426132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 2C9 (CYP2C9) polymorphisms in Chinese Li population.
    Ding Y; Yang D; Zhou L; He P; Yao J; Xie P; Lin D; Sun D; Sun P; Li Q; Geng T; Jin T
    Int J Clin Exp Med; 2015; 8(11):21024-33. PubMed ID: 26885033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations.
    Pedersen RS; Brasch-Andersen C; Sim SC; Bergmann TK; Halling J; Petersen MS; Weihe P; Edvardsen H; Kristensen VN; Brøsen K; Ingelman-Sundberg M
    Eur J Clin Pharmacol; 2010 Dec; 66(12):1199-205. PubMed ID: 20665013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population.
    Giri AK; Khan NM; Grover S; Kaur I; Basu A; Tandon N; Scaria V; ; ; Kukreti R; Brahmachari SK; Bharadwaj D
    Pharmacogenomics; 2014 Jul; 15(10):1337-54. PubMed ID: 25155935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance dose.
    Chaudhry AS; Urban TJ; Lamba JK; Birnbaum AK; Remmel RP; Subramanian M; Strom S; You JH; Kasperaviciute D; Catarino CB; Radtke RA; Sisodiya SM; Goldstein DB; Schuetz EG
    J Pharmacol Exp Ther; 2010 Feb; 332(2):599-611. PubMed ID: 19855097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5'-Flanking region polymorphisms of CYP2C9 and their relationship to S-warfarin metabolism in white and Japanese patients.
    Takahashi H; Ieiri I; Wilkinson GR; Mayo G; Kashima T; Kimura S; Otsubo K; Echizen H
    Blood; 2004 Apr; 103(8):3055-7. PubMed ID: 15070684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2C9*3 allelic variant is associated with metabolism of irbesartan in Chinese population.
    Hong X; Zhang S; Mao G; Jiang S; Zhang Y; Yu Y; Tang G; Xing H; Xu X
    Eur J Clin Pharmacol; 2005 Oct; 61(9):627-34. PubMed ID: 16094537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous Expression and Functional Characterization of Novel CYP2C9 Variants Identified in the Alaska Native People.
    McDonald MG; Henderson LM; Ray S; Yeung CK; Johnson AL; Kowalski JP; Hanenberg H; Wiek C; Thummel KE; Rettie AE
    J Pharmacol Exp Ther; 2020 Aug; 374(2):233-240. PubMed ID: 32423989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence variation and linkage disequilibrium in the GABA transporter-1 gene (SLC6A1) in five populations: implications for pharmacogenetic research.
    Hirunsatit R; Ilomäki R; Malison R; Räsänen P; Ilomäki E; Kranzler HR; Kosten T; Sughondhabirom A; Thavichachart N; Tangwongchai S; Listman J; Mutirangura A; Gelernter J; Lappalainen J
    BMC Genet; 2007 Oct; 8():71. PubMed ID: 17941974
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.